New migraine drug atogepant shows quick relief

A drug recently approved to prevent migraine may start working right away, according to a study published in the December 23, 2024, online issue of Neurology, the medical journal of the American Academy of Neurology.

Opinion | Out With the Old, In With the New

Fred Pelzman is an associate professor of medicine at Weill Cornell, and has been a practicing internist for nearly 30 years. He is medical director

December 31, 2024

Advanced Analytics Can Change the Game for Consumer Healthcare Services

Sean Crandell. SVP of Healthcare Economics at MultiPlan Data has become the lifeblood of healthcare, making it possible to gain granular insights that enable more

January 5, 2024

Improving COPD outcomes through enhanced inhaler education and technique

Inhaler misuse leading to inadequate medication delivery impacts a person’s ability to manage symptoms of chronic obstructive pulmonary disease (COPD), and additional education about proper

August 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.